Pub Date : 2024-11-14DOI: 10.1016/j.jdin.2024.09.015
Geeta Yadav MD , Yvette Miller-Monthrope MD , Jaggi Rao MD , David N. Adam MD , Rachel N. Asiniwasis MD , Parbeer Grewal MD , Christina Han MD , Marissa Joseph MD , Richard G. Langley MD , Charles W. Lynde MD , Andrei Metelitsa MD , Loukia Mitsos MD, PhD , Boluwaji Ogunyemi MD , Kerri S. Purdy MD , Maxwell Sauder MD , Jensen Yeung MD
Background
There is limited evidence on treating psoriasis patients with skin of color (SOC), contributing to disparities in accessing appropriate care for these patients.
Objectives
This study aimed to develop consensus statements defining SOC terminology and addressing needs to optimize the clinical management of psoriasis in patients with SOC.
Methods
Using the modified Delphi methodology 16 Canadian dermatologists with expertise in psoriasis developed consensus statements. Four core faculty members drove the content of the study, and 12 additional panel members were consulted to vote and provide consensus on the content produced by the core faculty. At a final meeting, the full panel revised and voted on the final consensus statements.
Results
The exercise resulted in 11 consensus statements on SOC terminology, as well as 5 primary and 4 secondary statements on clinical presentation and differential diagnosis, and treatment guidelines based on evidence and expert opinion. Four additional consensus statements on current assessment tools and access to care were developed based solely on expert opinion.
Limitations
The available evidence was limited, low quality, and inappropriate for formal quality assessment.
Conclusions
The consensus statements developed in this study may provide valuable guidance to the dermatology community treating psoriasis patients with SOC.
{"title":"Optimizing the management of psoriasis in patients with skin of color: A Canadian Delphi consensus","authors":"Geeta Yadav MD , Yvette Miller-Monthrope MD , Jaggi Rao MD , David N. Adam MD , Rachel N. Asiniwasis MD , Parbeer Grewal MD , Christina Han MD , Marissa Joseph MD , Richard G. Langley MD , Charles W. Lynde MD , Andrei Metelitsa MD , Loukia Mitsos MD, PhD , Boluwaji Ogunyemi MD , Kerri S. Purdy MD , Maxwell Sauder MD , Jensen Yeung MD","doi":"10.1016/j.jdin.2024.09.015","DOIUrl":"10.1016/j.jdin.2024.09.015","url":null,"abstract":"<div><h3>Background</h3><div>There is limited evidence on treating psoriasis patients with skin of color (SOC), contributing to disparities in accessing appropriate care for these patients.</div></div><div><h3>Objectives</h3><div>This study aimed to develop consensus statements defining SOC terminology and addressing needs to optimize the clinical management of psoriasis in patients with SOC.</div></div><div><h3>Methods</h3><div>Using the modified Delphi methodology 16 Canadian dermatologists with expertise in psoriasis developed consensus statements. Four core faculty members drove the content of the study, and 12 additional panel members were consulted to vote and provide consensus on the content produced by the core faculty. At a final meeting, the full panel revised and voted on the final consensus statements.</div></div><div><h3>Results</h3><div>The exercise resulted in 11 consensus statements on SOC terminology, as well as 5 primary and 4 secondary statements on clinical presentation and differential diagnosis, and treatment guidelines based on evidence and expert opinion. Four additional consensus statements on current assessment tools and access to care were developed based solely on expert opinion.</div></div><div><h3>Limitations</h3><div>The available evidence was limited, low quality, and inappropriate for formal quality assessment.</div></div><div><h3>Conclusions</h3><div>The consensus statements developed in this study may provide valuable guidance to the dermatology community treating psoriasis patients with SOC.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"19 ","pages":"Pages 12-20"},"PeriodicalIF":0.0,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-30DOI: 10.1016/j.jdin.2024.09.010
Samuel X. Tan MD , Nicholas Michael Muller MD , Chenhao Zhou PhD , Euan Walpole MD , B. Mark Smithers MBBS , David C. Whiteman MBBS (Hons), PhD , Kiarash Khosrotehrani MD, PhD
{"title":"Prognostic markers could extend adjuvant immunotherapy to high-risk stage IB/IIA melanoma: A modeling study","authors":"Samuel X. Tan MD , Nicholas Michael Muller MD , Chenhao Zhou PhD , Euan Walpole MD , B. Mark Smithers MBBS , David C. Whiteman MBBS (Hons), PhD , Kiarash Khosrotehrani MD, PhD","doi":"10.1016/j.jdin.2024.09.010","DOIUrl":"10.1016/j.jdin.2024.09.010","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 86-87"},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142706936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.1016/j.jdin.2024.08.012
Roel Van Overmeire PhD , Helena Van Deynse MS , Johan Vansintejan PhD, MD , Emilie Muysewinkel MS , Lara Vesentini PhD , Johan Bilsen PhD
{"title":"Among psoriasis patients in Flanders, Belgium, a third has sexual dysfunction and almost half depression symptoms","authors":"Roel Van Overmeire PhD , Helena Van Deynse MS , Johan Vansintejan PhD, MD , Emilie Muysewinkel MS , Lara Vesentini PhD , Johan Bilsen PhD","doi":"10.1016/j.jdin.2024.08.012","DOIUrl":"10.1016/j.jdin.2024.08.012","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 81-82"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142706935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-26DOI: 10.1016/j.jdin.2024.07.029
Nourine A. Kamili PhD, Turkan Banu Karatas BA, Taha Osman Mohammed MD, Nujood Alzahrani MD, Travis W. Blalock MD
{"title":"Paperclip as a tool for steatocystoma extraction","authors":"Nourine A. Kamili PhD, Turkan Banu Karatas BA, Taha Osman Mohammed MD, Nujood Alzahrani MD, Travis W. Blalock MD","doi":"10.1016/j.jdin.2024.07.029","DOIUrl":"10.1016/j.jdin.2024.07.029","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 88-89"},"PeriodicalIF":0.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142706937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-18DOI: 10.1016/j.jdin.2024.08.024
Kathy Dempsey PhD , Genevieve Ho MD , Serigne N. Lo PhD , Janet McKeown MBiostat , Caroline G. Watts PhD , Anne E. Cust PhD , Pascale Guitera PhD , Richard A. Scolyer MD , John F. Thompson MD , Rachael L. Morton PhD
Background
Factors associated with nonadherence to guideline-recommended complete excision of suspicious cutaneous lesions are unclear.
Objective
The purpose of this study was to analyze patient, melanoma, and clinician factors associated with initial diagnostic biopsy type and determine whether unwarranted variation from guidelines occurred.
Methods
This population-based, cohort study involved the analysis of data from questionnaires completed by clinicians who managed patients with newly diagnosed, histopathologically confirmed primary invasive cutaneous melanomas reported to the New South Wales Cancer Registry between 2006 and 2007.
Results
Of the 2267 biopsies, complete excision was attempted in 69.1% of cases but histologically incomplete in 14.0%. Multivariable regression analyses showed that complete excision was more likely than incision biopsy in patients <70 years (P = .016), shave biopsy in patients <80 years (P = .034), shave biopsy in melanomas of Breslow thickness 0.8-1.0 mm or 2.1-4.0 mm (P = .039) than either punch (P < .001) or shave biopsy (P < .003) in melanomas on trunk or limbs, and punch biopsy when treated by a surgeon (P < .001). Complete excision was less likely than punch biopsies in women (P < .003), with lentigo maligna melanoma or unknown histopathology (P = .004); shave biopsy in patients with lentigo maligna melanoma, or other melanoma subtype (P = .003); punch, shave, or incision biopsy when treated by a dermatologist (P < .001).
Limitations
Generalizability of these findings may be limited to the time of data collection.
Conclusions
Guideline adherence for biopsy type undertaken for clinically suspected melanoma appeared to be suboptimal.
{"title":"Variation in initial biopsy technique for primary melanoma diagnosis: A population-based cohort study in New South Wales, Australia","authors":"Kathy Dempsey PhD , Genevieve Ho MD , Serigne N. Lo PhD , Janet McKeown MBiostat , Caroline G. Watts PhD , Anne E. Cust PhD , Pascale Guitera PhD , Richard A. Scolyer MD , John F. Thompson MD , Rachael L. Morton PhD","doi":"10.1016/j.jdin.2024.08.024","DOIUrl":"10.1016/j.jdin.2024.08.024","url":null,"abstract":"<div><h3>Background</h3><div>Factors associated with nonadherence to guideline-recommended complete excision of suspicious cutaneous lesions are unclear.</div></div><div><h3>Objective</h3><div>The purpose of this study was to analyze patient, melanoma, and clinician factors associated with initial diagnostic biopsy type and determine whether unwarranted variation from guidelines occurred.</div></div><div><h3>Methods</h3><div>This population-based, cohort study involved the analysis of data from questionnaires completed by clinicians who managed patients with newly diagnosed, histopathologically confirmed primary invasive cutaneous melanomas reported to the New South Wales Cancer Registry between 2006 and 2007.</div></div><div><h3>Results</h3><div>Of the 2267 biopsies, complete excision was attempted in 69.1% of cases but histologically incomplete in 14.0%. Multivariable regression analyses showed that complete excision was more likely than incision biopsy in patients <70 years (<em>P</em> = .016), shave biopsy in patients <80 years (<em>P</em> = .034), shave biopsy in melanomas of Breslow thickness 0.8-1.0 mm or 2.1-4.0 mm (<em>P</em> = .039) than either punch (<em>P</em> < .001) or shave biopsy (<em>P</em> < .003) in melanomas on trunk or limbs, and punch biopsy when treated by a surgeon (<em>P</em> < .001). Complete excision was less likely than punch biopsies in women (<em>P</em> < .003), with lentigo maligna melanoma or unknown histopathology (<em>P</em> = .004); shave biopsy in patients with lentigo maligna melanoma, or other melanoma subtype (<em>P</em> = .003); punch, shave, or incision biopsy when treated by a dermatologist (<em>P</em> < .001).</div></div><div><h3>Limitations</h3><div>Generalizability of these findings may be limited to the time of data collection.</div></div><div><h3>Conclusions</h3><div>Guideline adherence for biopsy type undertaken for clinically suspected melanoma appeared to be suboptimal.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 90-100"},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142706934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-16DOI: 10.1016/j.jdin.2024.10.001
Jonathan Kantor MD, MSc, MSCE
{"title":"The great automatic grammatizator: On the use and misuse of large language models in scientific and academic writing","authors":"Jonathan Kantor MD, MSc, MSCE","doi":"10.1016/j.jdin.2024.10.001","DOIUrl":"10.1016/j.jdin.2024.10.001","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 79-80"},"PeriodicalIF":0.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142650748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-16DOI: 10.1016/j.jdin.2024.09.005
Courtney A. Smith MS , Deeti Pithadia MD , Diana Wang MD, PhD , Marcia Hogeling MD , Carol E. Cheng MD
{"title":"Video synchronous isotretinoin management is associated with lower risk of patient attrition compared to in-person follow-up: A single-center cohort study involving propensity-score matched analysis of patients with acne","authors":"Courtney A. Smith MS , Deeti Pithadia MD , Diana Wang MD, PhD , Marcia Hogeling MD , Carol E. Cheng MD","doi":"10.1016/j.jdin.2024.09.005","DOIUrl":"10.1016/j.jdin.2024.09.005","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 35-37"},"PeriodicalIF":0.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-11DOI: 10.1016/j.jdin.2024.09.004
Alim Osman MS , Megan Jayne Ralston MS , Michael Christopher Povelaitis BS , Mariela Mitre MD, PhD
{"title":"COVID-19 infection or vaccination and hidradenitis suppurativa: A systematic review","authors":"Alim Osman MS , Megan Jayne Ralston MS , Michael Christopher Povelaitis BS , Mariela Mitre MD, PhD","doi":"10.1016/j.jdin.2024.09.004","DOIUrl":"10.1016/j.jdin.2024.09.004","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 32-34"},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142661807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号